Background: Vertical transmission is an important route of transmission for hepatitis B virus infection. Despite the introduction of HBV vaccine in the extended immunization program in 2005, Cameroon has remained a hyper-endemic area. The aim of this study was to determine the seroprevalence of hepatitis B Virus among antenatal clinic attenders in Penka-Michel-Cameroon, and to identify potential risk factors associated with the infection for a better prevention of the disease. Mabeku et al.; JAMMR, 29(3): 1-12, 2019; Article no.JAMMR.33102 2 Study Design: The study was a case control study conducted in four reference hospitals in PenkaMichel, a rural area in west region of Cameroon during April to July 2014. Methodology: Six hundred and forty three (643) pregnant women were recruited. The DiaSpot HBsAg in vitro diagnostic test strips were first used. Positive samples were further confirmed for HBsAg, HBeAg, anti-HBs, anti-HBe and anti-HBc using an immunoassay kit. Liver enzymes (ALT, AST and ALP) were also evaluated for HBsAg positive samples using TECO DIAGNOSTICS kit. A structured questionnaire was used to collect information on sociodemographic parameters and predisposing risk factors of hepatitis B from each patient. Data collected was analyzed using Graph Pad prism version 5.03. Results: The prevalence of hepatitis B infection (HBsAg) in our setting was 4.7%. Fifty percent of HBsAg positive women were also HBeAg positive and 46.7% of them lack antibodies against hepatitis B e antigen. All the HBsAg positive women had previous contact with HBV and just 3.3% of them were immunized against HBV. Women in the age groups 31-35 years were significantly more affected (X 2 16.95, P = .0045). Only a history of a contact with hepatitis B infection was significantly associated with HBsAg and HBeAg positivity (X 2 27.45, P = .0001; X 2 25.31, P = .0003). Conclusion: Administration of HBIG in combination with hepatitis B vaccine as post-exposure prophylaxis for infants born to HBV infected mothers is of paramount importance. In addition, universal HBsAg screening of all pregnant women will greatly assist in reducing the maternal transmission of HBV in Cameroon.
INTRODUCTION
Hepatitis B virus (HBV) infection is a major global health problem. It is estimated that more than two billion people have been infected with HBV world wide and 350 million people have chronic infection of whom 65 million live on the African continent [1] . Sub-Saharan Africa has a high endemicity, and more than 50 million people are believed to be chronic carriers of the HBV [2] . Infection with hepatitis B virus (HBV) leads to a wide spectrum of clinical presentations, ranging from asymptomatic carrier state to acute selflimiting infection or fulminant hepatic failure, chronic hepatitis with progression to cirrhosis, and hepatocellular carcinoma (HCC) [3, 4] . The hepatitis B surface antigen (HBsAg) in serum is the first seromarker to indicate active HBV infection, either acute or chronic, whilst the soluble extractable protein, the Hepatitis e antigen (HBeAg) is a marker for the highly infectious state [5] . The virus is transmitted through infected blood or other body fluids, and vertically (mother to child) in the perinatal period. Transmission of HBV from carrier mothers to their babies during the perinatal period appears to be the most important factor in determining the prevalence of infection in high endemicity areas [6, 7] . Without immune prophylaxis, in mothers who are both HBsAg and HBeAg positive, the risk for transmission to the baby is between 70 and 90% by 6 months of age, whereas in the case of mothers who are HBsAg positive, but HBeAg negative, it is less than 10% [8] [9] [10] .
The risk for development of chronic hepatitis B infection varies inversely with the age at which infection occurs, 90% of affected infants develop chronic infection as opposed to 30-50% of under-five children and 6% of children above five years of age [11, 12] . Chronic hepatitis B infection acquired in childhood carries a 25% risk for development of chronic liver disease, cirrhosis or hepatocellular carcinoma [13] . Hence, it is imperative to prevent mother to child transmission. A combination of active and passive immune prophylaxis is the optimum strategy to prevent HBV infection in babies of HBsAg positive mothers. A combination of hepatitis B immune globulin (HBIG) and hepatitis B vaccination initiated within 24 hours of delivery has been shown to protect 85 to 95% of babies whose mothers were positive for both HBsAg and HBeAg [14] . However, studies have shown significant gaps in hospital practices and policies to prevent vertical transmission of hepatitis B [15] . As a result of this, maternal screening is necessary for the treatment of newborns in the endemic areas. In addition, viral hepatitis during pregnancy is associated with a high risk of maternal complications, and has been reported as a leading cause of maternal mortality [16] .
Cameroon has high endemicity of HBV infection, with population prevalence rate up to 8% [17] .
Many of these people may not be aware of the infection and hence fail to seek appropriate medical attention therefore progressing to chronic liver disease, cirrhosis and hepatocellular carcinoma. Most of the previous studies carried out on HBsAg among general population, principally in urban setting, [18] [19] [20] [21] showed that Cameroon has remained a hyper-endemic area for hepatitis B virus infection, despite the introduction of HBV vaccine in the extended immunization program in 2005. To the best of our knowledge, few studies have been done on the prevalence of HBV among pregnant women in Cameroon particularly in urban setting [22] [23] [24] . As a result, guidelines and other adequate information on the prevention and control strategies are lacking in rural areas. The objectives of this study therefore are to determine the seroprevalence of hepatitis B virus among pregnant women attending antenatal care in Penka-Michel, a rural setting of Cameroon and to identify potential risk factors associated with the infection for a better management of the disease.
METHODS

Study Area
The study was performed in Penka-Michel, a rural area covering about 276 square kilometers, in west region of Cameroon with 124 880 people and a growth rate of 6.8% per year. Penka-Michel is located between latitude 21.52, 5º and 31.41, 5º north of the equator and longitude 7.39, 10º and 20, 10º east of the Greenwich Meridian. It has an altitude of about 1500 m above sea level [25] . It enjoys two distinct seasons, a short dry and a long rainy season. The highest rainfall registered in a year could reach 345.1 mm and the thermal amplitude between the hottest month of the year (March: 21.5ºC) and the coolness one (August: 18.9ºC) is 2.6ºC [25] . Penka-Michel is a nearest rural city of the University of Dschang and has been endowed with agricultural viability.
Study Population
This was a case control study conducted at the District Medical Center of Balessing (CMA-B), the District Medical Center of Bansoa chefferie (CMA-BC), the District Medical Center of Eglise Evangelique du Cameroun (CAA-EEC) and the District Hospital of Penka-Michel a rural area in the west region of Cameroon. These four health centers are the biggest hospitals in Penka-Michel and its environs. Thus, our sample was representative of all variety of pregnant women in Penka-Michel. The study recruited 643 pregnant women attending antenatal care in the four above cited hospitals during the study period. The sample size was calculated using Lorenz formula as follows N = z 2 p (1-p) / & 2 (where z = the standard normal deviation at 1.96 (which corresponds to a 95% confidence interval), p = the prevalence of Hepatitis B in the general Cameroonian population, estimated at 10%; and & (degree of precision expected) = 0.05). The study lasted four months, from April to July 2014 and we employed a consecutive sampling for data collection, requesting consent from all antenatal clinic attendees in the selected health facilities during the study period. We excluded all women who refused to give consent.
Variables
Following informed consent, all pregnant women were interviewed using a standard questionnaire. This questionnaire was applied to collect relevant socio-demographic data of the women such as age, occupation, education status (non formal education, primary level, secondary level and university or more level), marital status (single, married), gravidity (Primigravidae, multigravidae) and gestational age. It was also used to collect information on predisposing factors for hepatitis B infection in order to test their association with HBV infection among pregnant women in our community. These included a previous history of blood transfusion, a history of previous surgery (cesarean sections, dilatations and curettage for miscarriage and retained placenta), history of previous tissue transplant, a history of scarifications/tattoos, type of marriage (monogamous or polygamous) polygamous used as a proxy indicator for multiple sexual partners.
Sample Collection
After completion of the questionnaire, 5 ml of blood was aseptically collected from each participant by clean venepuncture and dispensed into a clean, dry glass test tube. The blood samples were then spun in a centrifuge at 2,500 rpm for 5 minutes to separate the serum which was used for biological analysis.
Serological Analysis
After centrifugation, the serum was first tested for Hepatitis B surface antigen (HBsAg) using the Dia Spot® HBsAg Test strips (Dia Spot Diagnostics, USA). All initially positive tests were confirmed for Hepatitis B surface antigen (HBsAg) using ELISA kit (OnSite HBV-5 Rapid Test, CTK Biotech, Inc. USA). In order to determine recovery and immunity from hepatitis B virus infection, initially positive tests were evaluated for the Hepatitis B surface antibody (anti-HBs) using the same ELISA kit (OnSite HBV-5 Rapid Test, CTK Biotech, Inc. USA). Confirmed HBsAg positive samples were also chosen for evaluation of infectivity by testing for the Hepatitis B e antigen (HBeAg) and the Hepatitis B e antibody (anti-HBe) using the same ELISA kit above. Confirmed HBsAg positive samples were equally evaluated for the Hepatitis B core antibody (anti-HBc) in order to determine previous exposure to HBV within the study population using also the same ELISA kit. All test procedures were carried out according to the manufacturers'
instructions. Hepatocellular damage for HBsAg positive samples were also evaluated by estimating the activities of serum aminotransferase (ALT and AST) and alkaline phosphatase (ALP) using diagnostic kit (TECO DIAGNOSTICS, USA).
Statistical Analysis
The data collected were first checked for obvious errors before they were entered into a computer. Using GraphPad prism version 5.03, the data generated were analyzed with chi-squared (χ2) test, reporting corresponding p-values. The level of statistical significance for the study was set at p < 0.05. A control group made of pregnant women who were HBsAg negative was used to compare the strength of the association between reported risk factors and infection with Hepatitis B virus. The odds ratio and the corresponding 95% confidence intervals (95% CI) were used to summarize the strength of association.
RESULTS
Socio-demographic Characteristics
A total of 643 pregnant women were enrolled in this study. Their age varied between 15 and 50 years with a mean age of 27.1 ± 2.51 years. Majority of the study population are in the 21 to 25 years age group constituting 25% of the total population. Most of these women (80%) were married with 182 (35.4%) in monogamous and 332 (64.6%) in polygamous marriages. Over 92 % of the women possessed primary and secondary levels of formal education, with major occupations as housewives (47.43%) and farmers (18.2%). The subjects had the least percentage of women with university level of formal education (3.11%), while health workers constituted the least occupational group (2.64%). In relation to gravidity, most of the subjects were multiparous (76.04%), whereas few of them had more than 6 children (18.20%). Sixty three (9.8%) of the women were at the first trimester of gestation while 254 (39.5%) and 326 (50.7%) were at second and third trimester, respectively. Table 1 summarizes the sociodemographic characteristics of the study participants. Among the 30 women who tested positive for HBsAg, 15 (50%) tested positive for HBeAg, thus indicating that this proportion of patients was highly infectious, and therefore likely to transmit the virus to their unborn babies.
Prevalence of Hepatitis B virus Infection
Results of testing for anti-HBe for the 30 HBsAg (+) patients showed that, 46.7% (n = 14) lacked anti-HBe antibody. This implies a higher proportion of women were thus at risk of active viral replication. The remainder (53.3%) had antiHBe antibody, indicating they were seroconverting.
Hepatitis B core antibody (anti-HBc) appears at the onset of symptoms in acute Hepatitis B and persists for life. This marker was also evaluated amongst the 30 women tested positive for HBsAg. Of these, 30 (100%) were positive for anti-HBc, hence had serologic evidence of previous HBV exposure or ongoing infection with hepatitis B virus within an undefined time frame. The strength of the association between sociodemographic parameters evaluated and infection with Hepatitis B virus was studied. Our finding showed a statistically significant relationship between age group and HBsAg, HBeAg status, with a significant higher risk of being HBsAg positive amongst those in the age group 31 to 35 years (P = .0045) and age group 15-20 (P = .0046) for being HBeAg positive, relative to those in other age group ( Table 2 ).
The strength of the association between women's occupation and HBsAg, HBeAg status was also statistically significant (P ˂ .05), with a significantly higher risk of being infected amongst health workers, relative to those in other occupation group. Our findings showed that 23.53 % (P = .0001) and 17.6 % (P = .0003) of health workers were respectively sero-positive for HBsAg and HBeAg (Table 3 ).
Unlike the above socio-demographic parameters, the association between gravidity, marital status, educational level and HBsAg or HBeAg status was no statistically significant. The mean gravidity was 3.7 ±1.1. There was a positive relationship between gravidity and HBsAg, HBeAg status (Fig. 1) . Twenty one (70 %) of the 30 pregnant women that were sero-positive to HBsAg were multiparous. Thirteen (87 %) of the 15 pregnant women that were sero-positive to both HBsAg and HBeAg were multiparous. An inverse relationship between educational level and HBsAg and HBeAg status was obtained with women with university level of education more affected than those with other levels of education (Fig. 2) .
In terms of marital status, HBsAg and HBeAg positivity was higher among the married mothers (5.25 and 2.53 %) than among the single (2.53 and 1.55 %) (Fig. 3 ). study populations between our study and those previous studies could explain such results. One may estimate that urban dwellers probably have a higher risk of acquiring the infection that those in rural settings. This hypothesis however needs to be evaluated. Our prevalence is also lower than the 8.3% reported by Luka et al. (2008) [30] in an urban setting in Nigeria and by Eke et al. (2011) [31] in a rural setting still in Nigeria, the 9.3% HBsAg prevalence reported in Kenya [32] and the 10.7% HBsAg prevalence in Burkina Faso [33] . Our result is significantly lower than the 25% prevalence of HBsAg reported by Madzime et al. (1999) [34] among pregnant women in Zimbabwe. On the contrary, our results are higher than the 1.2% HBsAg prevalence reported among antenatal clinic attendees in South Africa [35] . Geographical differences may explain the variation in seroprevalence rates of HBsAg among pregnant women from different countries. Studies have shown that variation may even exist among regions of the same country [36, 37] .
Hepatitis B Infection and Risk Factors
DISCUSSION
All our HBsAg positive participants showed evidence of previous exposure to HBV as evidenced by the 100% of anti-HBc positivity within this population. This proportion is comparable to that reported by Ndumbe et al. (1994) [22] among pregnant women in a rural setting in Cameroon (85%). It is however higher than the anti-HBc seroprevalence among pregnant women in the developed world, with reports ranging from 7.1% in Switzerland [38] , through 13.4% in France [39] , and 29.65% in China [40] . These results highlight the fact that HBV is very much present in our community and the risk of HBV acquisition in our community is high. Despite the high risk of acquisition of HBV in our community, just few of pregnant women have ever been vaccinated against HBV as evidenced by the 3.3% of anti-HBs prevalence within our study population. This shows a massive lack of awareness concerning HBV infection in our study population and the need for anti HBV vaccination.
It is known that the risk of vertical transmission and resulting chronic carrier infection from an HBsAg (+) mother to her baby is approximately 90% in HBeAg positive pregnant women with high HBV DNA titres [41, 42] . In our study, we found that 50 % of HBsAg positive women were equally HBeAg positive, indicating that pregnant women could serve as an important reservoir to fuel the perinatal and childhood transmission of HBV within our community. Furthermore, our findings indicated that 46.7% of HBsAg positive patients lacked anti-HBe antibodies, which is an indirect indicator of the active viral replication. This observation indicates the active infection status of those women. This emphasizes the need to equip mothers with knowledge to prevent horizontal transmission of hepatitis B infection and to sensitize them on the importance of anti HBV vaccination.
We also found that most of the patients fell within the age group 21-25, 26-30 and 31-35 because these were the majority age groups that attended the antenatal clinics of the hospitals surveyed in this study. From table 2, the age group most affected using HBsAg is 31-35 years (10.4%) followed by 41+ (9.5%), so using age group the prevalence was statistically significant between women aged greater than 31 years than those aged less than 31 years (P = .0045). The prevalence of HBeAg was also significantly (P = .0095) higher among the 15-20 years age groups (6/111; 5.4%). This age distribution was not similar to the findings of Ndumbe et al. (1994) [22] [43] which reported that HBV was detected at a higher rate in pregnant women aged greater than 25 years than in women aged less than 25 years. However, the difference was not statistically significant. Habiba and Memon (2007) [44] from Pakistan also reported that the majority of those that tested positive to HBV were in the age range 25-35 years which was similar to this present study. Other studies also observed a high prevalence rate of HBV in pregnant women greater than 25 years than those less than 25 years [26, 45] . A possible reason for the higher HBsAg prevalence in the age group greater than 25 years is the fact that the age groups 21-30 years were the most sexually active and fertile. The increased age among HBV positive mothers may be also due to increase in the chance of exposure to HBV for each pregnancy. This observation is further highlighted by the fact that the HBsAg and HBeAg seroprevalence rate increased with gravidity even though this was not statistically significant. Azhar et al. (2012) [46] reported a higher frequency of HBV infection among multigravidae. Multigravidae women might be at increased risk of HBV infection because of repeated risk of exposure to contaminated surfaces and instruments during delivery [47] . Therefore, with each pregnancy and childbirth chances of exposure to HBV become greater.
In relation to marital status, HBsAg and HBeAg seropositivity was higher among the married mothers (5.25 and 2.53 %) than among the single (2.53 and 1.55 %) (Fig. 3) . Other studies have found higher prevalence among married women or formerly married women. Such variations may imply that marital status per se is not a risk factor for HBV infection but an indicator to consider the sexual partner as a risk factor.
This study found a correlation in terms of occupation and HBsAg, HBeAg seropositivity. The female health workers constituted the bulk of HBV seropositivity cases with 23.53 % for HBsAg and 17.6 % for HBeAg, this was statistically significant (P = .0001 and P = .0003 respectively). The reason for this is clear, since those women are frequently in contact with patients or their body secretion. Hence, our findings are in accordance with other reports which indicate that the risk of HBV transmission is high in people who are frequently in contact with infected HBV subjects [31, 48, 49] . Possible measures could include universal vaccination against HBV of at risk groups such as health workers, blood bank workers, and those with a contact known to be infected with HBV.
None of the female students in our study population was infected. The reason for this may be because of the awareness concerning transmission routes of HBV infection amongst women of this occupation group. This indicates the importance of education on prevention of high risk behaviors as a prevention strategy. One would have expected a positive relationship between educational status and HbsAg seropositivity with less educated women showing the highest positivity because of lack of knowledge concerning contraction routes or risk factors of HBV infection. However, the reverse was the case as the prevalence was higher among women with university level of education (3/20; 15%). Such variations may imply that possession of formal education is not perceived as a risk factor for HBV infection, since our findings showing that the HbsAg positivity amongst student women in our study population was null. It is likely that most of the women with university level of education enrolled in our study were no longer students at the time of the study and consequently were no longer considered as students. This brings to light the fact that after finishing with their school women do not apply their background knowledge in their daily livings, probably due to unemployment. This emphasizes the need of sensitization and education activities of Cameroonian population regarding the risks involved in Hepatitis B transmission and the importance of preventive strategies by our health authorities.
It was noted from this study that predisposing factor for HBV infection such as type of marriage and scarification marks or tattoos did not show a statistical significance.
In general, the increase in ALT, AST and ALP activities in blood are used usually for the detection of hepatocellular damage [50] . Following infection, the immune system attempts to clear the HBV by destroying infected hepatocytes with the consequence that liver enzymes are leaked out into the circulation across the damaged cell membranes [51] . Our findings shows that 73.33%, 60% and 53.33% of samples from HBsAg positive women tested had pathological values of ALAT, ASAT and ALP respectively, thus indicating hepatocellular damage and chronic hepatocellular disease among these patients. Our study equally indicates that none of the pregnant women of our study population was aware about their HBV status and hence failed to seek appropriate medical attention therefore may predispose them to progress to chronic liver disease, cirrhosis and hepatocellular carcinoma as evidenced by the high percent of pathological level of liver enzymes in their blood. This shows a massive lack of awareness concerning HBV infection in the general Cameroonian population and emphasizes once more the need of community sensitization activities by our health authorities on sensitizing the Cameroonian population about HBV infection, and the importance of anti HBV vaccination.
CONCLUSION
Our research findings highlight the fact that HBV is very much present in our community and that the risk of HBV acquisition in our community is high. Our study also shows that pregnant women could serve as an important reservoir to fuel vertical transmission of HBV within our community. Due to the high risk of developing chronic HBV infection among infants born to HBsAg positive mothers, administration of HBIG in combination with hepatitis B vaccine as postexposure prophylaxis is of paramount importance. Universal free HBsAg screening for all pregnant women and women of child bearing age in Cameroun is advocated.
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